针对狂犬病病毒的重组载体疫苗的构造和表征协议
Manar E Khalifa1, Muhammad Munir1
1Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YG, UK.
STAR protocols
|October 18, 2024
概括
这项研究详细介绍了使用重组载体疫苗方法制造新型狂犬病病毒 (RV) 疫苗的协议. 这些工程疫苗提供了一个有希望的策略,用于快速和经济有效的狂犬病免疫接种.
科学领域:
- 病毒学 病毒学
- 疫苗学 疫苗学 疫苗学
- 分子生物学分子生物学
背景情况:
- 重组载体疫苗提供了高效,适应性和成本效益的免疫解决方案.
- 狂犬病病毒 (RV) 构成了全球重大公共卫生威胁,需要创新的疫苗开发.
研究的目的:
- 建立针对狂犬病病毒 (RV) 复合载体疫苗的构建和表征的详细协议.
- 为疫苗开发设计表达RV糖蛋白 (G) 的复制能力较强的囊泡性口炎病毒 (rcVSV).
主要方法:
- 通过用RV G基因替换原生VSV糖蛋白 (G) 来生成rcVSV.
- 通过将婴儿仓鼠脏 (BHK-21) 细胞与抗基因VSVcDNA等离子体 (pVSV) 共同感染来恢复工程化rcVSV.
- 由此产生的rcVSV-RV-G构造的功能,结构和分子特征的全面描述.
主要成果:
- 成功生成具有复制能力的VSV载体,表达狂犬病病毒G基因.
- 详细的表征证实了复合病毒的完整性和功能.
- 为生产这些新型候选疫苗建立一个可复制的协议.
结论:
- 提出的协议使得用于狂犬病的重组载体疫苗的高效开发和表征成为可能.
- 设计的rcVSV-RV-G代表了未来狂犬病免疫战略的一个有希望的平台.
- 这项工作有助于推进用于控制狂犬病传播的疫苗技术.
相关概念视频
Recombinant DNA
Overview
Viral Structure
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Rabies
Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...


